S199: A PHASE 3, OPEN-LABEL, RANDOMIZED STUDY EVALUATING THE EFFICACY AND SAFETY OF SINGLE AGENT BELANTAMAB MAFODOTIN VS POMALIDOMIDE PLUS DEXAMETHASONE IN RELAPSED/REFRACTORY MULTIPLE MYELOMA (DREAMM-3)

ABSTRACT:

SUBMITTER: Dimopoulos M 

PROVIDER: S-EPMC10428262 | biostudies-literature | 2023 Aug

REPOSITORIES: biostudies-literature